ExpreS2ion Biotech (Sweden) Market Value

EXPRS2 Stock  SEK 20.85  1.87  9.85%   
ExpreS2ion Biotech's market value is the price at which a share of ExpreS2ion Biotech trades on a public exchange. It measures the collective expectations of ExpreS2ion Biotech Holding investors about its performance. ExpreS2ion Biotech is trading at 20.85 as of the 1st of December 2024, a 9.85 percent increase since the beginning of the trading day. The stock's open price was 18.98.
With this module, you can estimate the performance of a buy and hold strategy of ExpreS2ion Biotech Holding and determine expected loss or profit from investing in ExpreS2ion Biotech over a given investment horizon. Check out ExpreS2ion Biotech Correlation, ExpreS2ion Biotech Volatility and ExpreS2ion Biotech Alpha and Beta module to complement your research on ExpreS2ion Biotech.
Symbol

Please note, there is a significant difference between ExpreS2ion Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if ExpreS2ion Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ExpreS2ion Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ExpreS2ion Biotech 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ExpreS2ion Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ExpreS2ion Biotech.
0.00
11/01/2024
No Change 0.00  0.0 
In 31 days
12/01/2024
0.00
If you would invest  0.00  in ExpreS2ion Biotech on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding ExpreS2ion Biotech Holding or generate 0.0% return on investment in ExpreS2ion Biotech over 30 days. ExpreS2ion Biotech is related to or competes with Hansa Biopharma, Saniona AB, and Oncopeptides. ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology ... More

ExpreS2ion Biotech Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ExpreS2ion Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ExpreS2ion Biotech Holding upside and downside potential and time the market with a certain degree of confidence.

ExpreS2ion Biotech Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for ExpreS2ion Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ExpreS2ion Biotech's standard deviation. In reality, there are many statistical measures that can use ExpreS2ion Biotech historical prices to predict the future ExpreS2ion Biotech's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ExpreS2ion Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
13.5620.8528.14
Details
Intrinsic
Valuation
LowRealHigh
12.7320.0227.31
Details
Naive
Forecast
LowNextHigh
16.4823.7731.05
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
17.9619.8321.69
Details

ExpreS2ion Biotech Backtested Returns

ExpreS2ion Biotech secures Sharpe Ratio (or Efficiency) of -0.0815, which denotes the company had a -0.0815% return per unit of risk over the last 3 months. ExpreS2ion Biotech Holding exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ExpreS2ion Biotech's Variance of 53.31, mean deviation of 4.21, and Standard Deviation of 7.3 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.38, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ExpreS2ion Biotech will likely underperform. At this point, ExpreS2ion Biotech has a negative expected return of -0.59%. Please make sure to confirm ExpreS2ion Biotech's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if ExpreS2ion Biotech performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.16  

Very weak predictability

ExpreS2ion Biotech Holding has very weak predictability. Overlapping area represents the amount of predictability between ExpreS2ion Biotech time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ExpreS2ion Biotech price movement. The serial correlation of 0.16 indicates that over 16.0% of current ExpreS2ion Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient0.16
Spearman Rank Test0.37
Residual Average0.0
Price Variance1.01

ExpreS2ion Biotech lagged returns against current returns

Autocorrelation, which is ExpreS2ion Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ExpreS2ion Biotech's stock expected returns. We can calculate the autocorrelation of ExpreS2ion Biotech returns to help us make a trade decision. For example, suppose you find that ExpreS2ion Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

ExpreS2ion Biotech regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ExpreS2ion Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ExpreS2ion Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ExpreS2ion Biotech stock over time.
   Current vs Lagged Prices   
       Timeline  

ExpreS2ion Biotech Lagged Returns

When evaluating ExpreS2ion Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ExpreS2ion Biotech stock have on its future price. ExpreS2ion Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ExpreS2ion Biotech autocorrelation shows the relationship between ExpreS2ion Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in ExpreS2ion Biotech Holding.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in ExpreS2ion Stock

ExpreS2ion Biotech financial ratios help investors to determine whether ExpreS2ion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ExpreS2ion with respect to the benefits of owning ExpreS2ion Biotech security.